Advanced search
Publication Cover
Dialogues in Clinical Neuroscience Volume 22, 2020 - Issue 3
Submit an article Journal homepage
2,791
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Cannabinoids and their therapeutic applications in mental disorders


Los cannabinoides y sus aplicaciones terapéuticas en los trastornos mentales

Les cannabinoϊdes et leurs applications thérapeutiques dans les troubles mentaux

Maria Schermaa Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Italy
,
Anna Lisa Muntonib Neuroscience Institute, National Research Council of Italy (CNR), Cagliari, Italy
,
Gernot Riedelc Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, Scotland, United Kingdom
,
Walter Frattaa Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Italy
&
Paola Faddad Author affiliations: Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Italy; Neuroscience Institute, National Research Council of Italy (CNR), Cagliari, Italy; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, Scotland, United Kingdom (Gernot Riedel); National Neuroscience Institute, Pisa, ItalyCorrespondence[email protected]
Pages 271-279 | Published online: 01 Apr 2022

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Luke J Ney, Wole Akosile, Chris Davey, Louise Pitcher, Kim L Felmingham, Leah M Mayo, Matthew N Hill & Esben Strodl. (2023) Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective. Expert Review of Clinical Pharmacology 16:11, pages 1093-1108.
Read now
Ruhan Deniz Topuz, Yasemin Gorgulu & Milkibar Kyazim Uluturk. (2023) Could serum endocannabinoid and N-acylethanolamine levels be important in bipolar disorder?. The World Journal of Biological Psychiatry 24:4, pages 314-320.
Read now

Articles from other publishers (9)

Elizabeth A. Cairns, Melissa J. Benson, Miguel A. Bedoya-Pérez, Sara L. Macphail, Adith Mohan, Rhys Cohen, Perminder S. Sachdev & Iain S. McGregor. (2023) Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing. Frontiers in Pharmacology 14.
Crossref
Joseph A. Hirsch, Steven Mandel, Kurt T. Hegmann, Alexandra G. Stratyner, Stuart Gitlow, James B. Talmage & Christopher R. Brigham. (2023) Considerations for Determining Whether Drug Addiction Is a Disability. Guides Newsletter 28:2, pages 1-38.
Crossref
Jerry Liwono Yana, Cerina Lee, Dean T. Eurich, Jason R.B. Dyck, John G. Hanlon & Arsène Zongo. (2023) Risk of depressive disorders associated with medical cannabis authorization: A propensity score matched cohort study. Psychiatry Research 320, pages 115047.
Crossref
Sinikka L. Kvamme. (2022) With Medicine in Mind? Exploring the Relevance of Having Recreational Experience When Becoming a Medicinal Cannabis User. Contemporary Drug Problems 49:2, pages 192-212.
Crossref
Tapan Behl, Rashita Makkar, Aayush Sehgal, Sukhbir Singh, Hafiz A. Makeen, Mohammed Albratty, Hassan A. Alhazmi, Abdulkarim M. Meraya & Simona Bungau. (2022) Exploration of Multiverse Activities of Endocannabinoids in Biological Systems. International Journal of Molecular Sciences 23:10, pages 5734.
Crossref
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, Abraham B. Torregrosa, Gabriel Rubio, Marta Marín-Mayor, Gabriela B. Acosta, Maria Salud Garcia-Gutiérrez & Jorge Manzanares. (2022) Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders. International Journal of Molecular Sciences 23:9, pages 4764.
Crossref
Mustafa al'Absi & Alicia M. Allen. (2021) Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping. Frontiers in Psychology 12.
Crossref
Catherine Langlois, Stéphane Potvin, Atul Khullar & Smadar Valérie Tourjman. (2021) Down and High: Reflections Regarding Depression and Cannabis. Frontiers in Psychiatry 12.
Crossref
Philippe A. Melas, Maria Scherma, Walter Fratta, Carlo Cifani & Paola Fadda. (2021) Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research. International Journal of Molecular Sciences 22:4, pages 1863.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.